University of Pennsylvania's Perelman School of Medicine: Drug Combination for Women Suffering Miscarriages is Cost-Effective
April 03, 2020
April 03, 2020
PHILADELPHIA, Pennsylvania, April 3 [TNSmedicalresearch] -- The University of Pennsylvania's Perelman School of Medicine issued the following news release:
A pretreatment medication for women who suffer miscarriages - called mifepristone - is not only more clinically effective when combined with the standard of care drug, but also more cost effective, according to researchers at the Perelman School of Medicine at the University of Pennsylvania. A new economic analysis found the . . .
A pretreatment medication for women who suffer miscarriages - called mifepristone - is not only more clinically effective when combined with the standard of care drug, but also more cost effective, according to researchers at the Perelman School of Medicine at the University of Pennsylvania. A new economic analysis found the . . .